Altered metabolism of all-trans-retinoic acid in liposome-encapsulated form

Cancer Letters

Volumn 134, Issue 2, 1998, Pages 121-128

  Parthasarathy, Ranjani ^a   Mehta, Kapil ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

APL; Liposomes; P 450 dependent metabolism; Retinoic acid

Indexed keywords

CYTOCHROME P450; DRUG METABOLITE; LIPOSOME; RETINOIC ACID;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG METABOLISM; ENCAPSULATION; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; RAT; TERATOCARCINOMA;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG CARRIERS; ENZYME INHIBITORS; IMIDAZOLES; LIPOSOMES; MALE; MICROSOMES, LIVER; RATS; TERATOCARCINOMA; TESTICULAR NEOPLASMS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0032433391     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00226-2     Document Type: Article

References (37)

1. S. Shapiro, Retinoids and epithelial differentiation, in: M. Sherman (Ed.), Retinoids and Cell Differentiation, CRC Press, Boca Raton, FL, 1986, pp. 25-29.
2. Jetten A.M. Multistep process of squamous differentiation of tracheobronchial epithelial cells: role of retinoids. Dermatologica. 175:1986;37-44.
3. Meng-er H., Ye Y., Shu-rong C., Jin-ren C., Jia-Xiang L., Lin Z., Long-jun G., Zhen-yi W. Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 72:1988;567-572.
4. Lippman S., Kavanaugh J., Parades-Espinoza M., Delgadillo-Madrueno F., Parades-Casillas P., Hong W.K., Holdener E., Krakoff I.H. 13-cis-Retinoic acid plus interpheron alpha 2a: highly active systemic therapy for squamous therapy for squamous cell carcinoma of the cervix (see comments). J. Natl. Cancer Inst. 84:1992;241-245.
5. Lippman S., Parkinson D.R., Itri L.M., Weber R.S., Schantz S.P., Ota D.M., Schusterman M.A., Krakoff I.H., Gutterman J.U., Hong W.K. 13-cis-Retinoic acid plus interpheron alpha 2a: effective combination therapy for advanced squamous cell carcinoma of the skin (see comments). J. Natl. Cancer Inst. 84:1992;235-240.
6. Castaigne S., Chomienne C., Daniel M.T., Ballerini P., Berger R., Fenaux P., Degos L. All-trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia. Blood. 76:1990;1704-1709.
7. Warrell R.P. Jr., Frankel S.P., Miller W.H. Jr., Scheinberg D.A., Itri L.M., Hittelman W.N., Vyas R., Andreeff M., Tafuri A., Jakubowski A., Gabrilove J., Gordon M., Dmitrovsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N. Engl. J. Med. 324:1991;1385-1393.
8. Chen Z.X., Xue Y.Q., Zhang R., Tao R.F., Xia X.M., Li C., Wang W., Zu W.Y., Yao X.Z., Ling B.J. A clinical and experimental study on all-trans-retinoic acid-treated acute promyelocytic patients. Blood. 78:1991;1413-1419.
9. Warrell R.P., de The H., Wang Z.Y., Degos L. Acute promyelocytic leukemia (see comments). N. Engl. J. Med. 329:1993;177-189.
10. Muindi J., Frankel S.R., Miller W.H. Jr., Jakubowski A., Scheinberg D.A., Young C.W., Dmitrovsky E., Warrell R.P. Jr. Continuous treatment with all-trans-retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood. 79:1992;299-303.
11. Muindi J.R.F., Frankel S.R., Huselton C., DeGrazia F., Garland W.A. Clinical pharmacology of oral all-trans-retinoic acid in patients with APL. Cancer Res. 52:1992;2138-2142.
12. Rigas J.R., Francis P.A., Muindi J.R.F., Kris M.G., Huselton C., DeGrazia F., Orazem J.P., Young C.W., Warrell R.P. Constitutive variability in pharmacokinetics of the natural retinoid, all-trans-retinoic acid and its modulation by ketaconazole. J. Natl. Cancer Inst. 85:1993;1921-1926.
13. Trump D., Smith D., Stiff D., Adedoyin A., Bahnson R., Day R., Branch R. All-trans-retinoic acid (ATRA) in hormone refractory prostate cancer (HPRC): ineffectiveness due to failure of drug delivery? (abstract). Proc. Am. Soc. Clin. Oncol. 751:1994;241.
14. Weinstein J.N., Leserman L.D. Liposomes as drug carriers in cancer chemotherapy. Pharmacol. Ther. 24:1984;207-233.
15. Parthasarathy R., Sacks P.G., Harris D., Brock H., Mehta K. Interaction of liposome-associated all-trans-retinoic acid with squamous carcinoma cells. Cancer Chemother. Pharmacol. 34:1994;527-534.
16. Mehta K., Sadeghi T., McQueen T., Lopez-Berestein G. Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid. Leuk. Res. 18:1994;587-596.
17. Atencia R., Garcia-Sanz M., Unda F., Arechaga J. Apoptosis during retinoic acid-induced differentiation of F9 embryonal cells. Exp. Cell Res. 214:1994;663-667.
18. Van Wauve J.P., Coene M.C., Gossens J., Cools W., Monbalu J. Effects of cytochrome P-450 inhibitors on the in vivo metabolism of all-trans-retinoic acid. J. Pharmacol. Exp. Ther. 252:1990;365-369.
19. Roberts A.B., Nichols M.D., Newton D.L., Spoen M.B. In vitro metabolism of retinoic acid in hamster intestine and liver. J. Biol. Chem. 254:1979;6296-6302.
20. Gubler M.L., Sherman M.I. Metabolism of retinoids by embryonal carcinoma cells. J. Biol. Chem. 260:1985;9552-9558.
21. Van Wauve J.P., Nyen G.V., Coene M.C., Stoppie P., Cools W., Goossens J., Borghgraef P., Janssen P.A.L. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid mimetic-effects in vivo. J. Pharmacol. Exp. Ther. 261:1992;773-779.
22. Smith M.A., Parkinson D.R., Cheson B.D., Friedman M.A.J. Retinoids in cancer therapy. J. Clin. Oncol. 10:1992;839-864.
23. Hong W.K., Endicott J., Itri L.M., Doos W., Batsakis J.G., Bell R., Fofonoff S., Byers R., Atkinson N., Vaughan C., Toth B.B., Kramer A., Dimery I.W., Skipper P., Strong S. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med. 315:1986;1501-1505.
24. J.J. Kamm, K.O. Ashenfelter, C.W. Ehmann, Preclinical and clinical toxicology of selected retinoids, in: M.B. Sporn, A.B. Roberts, D.S. Goodman (Eds.), The Retinoids, Academic Press, New York, 1984, pp. 288-326.
25. Raz A., Bucana C., Fogler W.E., Poste G., Fidler I.J. Biochemical, morphological and ultrastructural studies on the uptake of liposomes by murine macrophages. Cancer Res. 41:1981;487-494.
26. Lautersztain J., Perez-Soler R., Turpin J., Khokhar A.R., Siddik A.H., Schimdt K., Lopez-Berestein G. Cellular pharmacology of liposomal cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in mouse resident peritoneal macrophages, kupffer cells and hepatocytes. Cancer Res. 48:1988;1300-1306.
27. Martin G. Teratocarcinomas and mammalian embryogenesis. Science. 209:1980;768-775.
28. Alonso A., Breur B., Stever B., Fischer J. The F9-EC cell line as a model for the analysis of differentiation. Int. J. Biol. 35:1991;389-397.
29. Strickland S., Smith K.K., Marotti K.R. Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell. 21:1980;347-355.
30. Williams J.B., Napoli J.L. Metabolism of retinoic acid and retinol during differentiation of F9 embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA. 82:1985;4658-4662.
31. Kraft J.C., Slikker W. Jr., Bailey J.R., Roberts L.G., Fischer B., Wittfoht W., Nau H. Plasma pharmacokinetics and metabolism of 13-cis- and all-trans-retinoic acid in the cynomolgus monkey and the identification of 13-cis- and all-trans-retinoyl-beta-glucoronides. A comparison to one human case study with isotretinoin. Drug Metab. Dispos. 19:1991;317-324.
32. White J.A., Beckett-Jones B., Guo Y., Dilworth J.F., Bonasoro J., Jones G., Petkovich M. cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RA1) identifies a novel family of cytochromes P450 (CYP26). J. Biol. Chem. 272:1997;18538-18541.
33. Lotan R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim. Biophys. Acta. 605:1980;33-91.
34. Lopez-Berestein G., Rosenblum M., Sadeghi T., Mehta K. Pharmacokinetics, tissue distribution and toxicology of tretinoin incorporated in liposomes. J. Lip. Res. 4:1994;689-700.
35. Lopez-Berestein G., Fainstein V., Hopfer R., Mehta K., Sullivan M.P., Keating M., Rosenblum M.G., Mehta R., Luna M., Hersh E.M., Reuben J., Juliano R.L., Bodey G.P. Liposomal amphotericin B for the treatment of sic fungal infections in patients with cancer: a preliminary study. J. Infect. Dis. 151:(4):1985;704-710.
36. Estey E., Thall P.F., Mehta K., Rosenblum M., Brewer T., Simmons V., Cabanillas F., Kurzrock R., Lopez-Berestein L. Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans-retinoic acid. Blood. 87:1996;3650-3654.
37. Frankel S.R., Eardley A., Lauwers G., Weiss M., Warrell R.P. Jr. The "retinoic acid syndrome" in acute promyelocytic leukemia (see comments). Ann. Intern. Med. 117:1992;292-296.